Fortis Malar Hospitals Completes Postal Ballot with Overwhelming Shareholder Support
Fortis Malar Hospitals successfully concluded its postal ballot process with overwhelming shareholder support exceeding 99.90% for all three board appointments. The company appointed Bidesh Chandra Paul as director and whole-time director, while re-appointing Shailaja Chandra as independent director for a second five-year term effective March 10, 2026.

*this image is generated using AI for illustrative purposes only.
Fortis Malar Hospitals Limited has successfully completed its postal ballot process with overwhelming shareholder approval for three key board appointments. The healthcare company received strong support across all resolutions, with approval rates exceeding 99.90% for each proposed appointment.
Postal Ballot Process Overview
The postal ballot concluded on March 27, 2026, with scrutinizer CS Mukesh Kumar Agarwal certifying the results. The company dispatched electronic notices on February 25, 2026, following the notice dated February 6, 2026, and published advertisements in Business Standard (English) and Rozana Spokesman (Punjabi) on February 26, 2026.
| Process Details: | Information |
|---|---|
| Record Date: | February 20, 2026 |
| Total Shareholders: | 31,228 |
| Participating Shareholders: | 125 |
| Voting Platform: | KFin Technologies Limited |
| Scrutinizer: | CS Mukesh Kumar Agarwal |
Board Appointments Approved
All three resolutions received requisite majority approval with exceptional shareholder support:
Resolution 1: Director Appointment
Mr. Bidesh Chandra Paul (DIN: 08596135) was appointed as director with 1,17,60,663 votes in favor, representing 99.9067% approval.
Resolution 2: Whole-Time Director Appointment
Mr. Bidesh Chandra Paul's appointment as whole-time director was approved with 1,17,60,662 votes in favor, achieving 99.9067% approval rate.
Resolution 3: Independent Director Re-appointment
Ms. Shailaja Chandra (DIN: 03320688) was re-appointed as independent director for a second term of 5 consecutive years effective from March 10, 2026, with 1,17,60,763 votes in favor representing 99.9075% approval.
Detailed Voting Results
| Resolution | Votes in Favor | Votes Against | Approval % |
|---|---|---|---|
| Director Appointment: | 1,17,60,663 | 10,983 | 99.9067% |
| Whole-Time Director: | 1,17,60,662 | 10,984 | 99.9067% |
| Independent Director: | 1,17,60,763 | 10,883 | 99.9075% |
Shareholder Participation Analysis
The voting demonstrated strong promoter group support with complete participation, while public participation remained limited. Out of 1,87,41,759 total shares, 1,17,71,646 shares participated in voting, representing 62.81% of outstanding shares.
| Shareholder Category | Total Shares | Votes Polled | Participation % |
|---|---|---|---|
| Promoter Group: | 1,17,52,402 | 1,17,52,402 | 100.00% |
| Public Institutions: | 18,023 | 0 | 0.00% |
| Public Non-Institutions: | 69,71,334 | 19,244 | 0.276% |
Regulatory Compliance
The postal ballot was conducted in accordance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and various MCA circulars. The company provided electronic voting facility only, with no physical postal ballot forms received. Two shareholders holding 15 equity shares abstained from voting across all resolutions.
Company Secretary Vinti Verma confirmed that all resolutions were deemed passed on March 27, 2026, strengthening the company's board composition and governance framework for future operations.
Historical Stock Returns for Fortis Malar Hospitals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +10.79% | -3.97% | -14.56% | -28.80% | -43.09% | -15.33% |
What strategic initiatives might Mr. Bidesh Chandra Paul implement as the new whole-time director to drive Fortis Malar's growth in the competitive healthcare sector?
How could the strengthened board composition impact Fortis Malar's expansion plans or potential mergers and acquisitions in the healthcare industry?
Will the low public shareholder participation rate (0.276%) prompt the company to enhance investor engagement strategies in future corporate decisions?


































